Del. HC: Rs. 1 Lakh Cost Imposed on Person Who Made Lord Hanuman Party in Property Dispute  ||  Ker. HC: Termination of 27 Weeks Pregnancy Citing Foetal Abnormalities Permitted  ||  SC: Inclined to Hold That Accused in One Case Shouldn’t be Denied Anticipatory Bail in Another Case  ||  Bom. HC: Bank Regis. with CERSAI has Priority Over DCST Against Proceeds of Enforce. under SARFAESI  ||  Bom. HC: Govt’s Amendment Exempting Private Schools from RTE Quota If Govt-Run School Nearby, Stayed  ||  Del. HC: Apart from ‘Good and Bad Touch’ Children Need to be Taught About ‘Virtual Touch’  ||  SC: Minimum 1/3rd Women's Reservation in SCBA Posts is on Experimental Basis  ||  SC: Can Apply Doctrine of ‘Lis Pendens’ Even if Section 52 of TPA Inapplicable in a State  ||  SC: Can Apply Doctrine of ‘Lis Pendens’ Even if Section 52 of TPA Inapplicable in a State  ||  Del HC: Accused’s Mobile Having Photos of Osama Bin Laden Not Enough to Label Him as ISIS Member    

Search Results for Tag : Breast Cancer

News

Kerala HC to Centre: Consider Compulsory Licensing of Drug Ribociclib(22.06.2022)

Kerala High Court has directed the Department for Promotion of Industry and Internal Trade to consider compulsory licensing of Ribociclib, a breast ca.....

Tags : Kerala High Court, Compulsory Licensing, Breast Cancer



Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Australia Court Rules Breast Cancer Gene Patent Cannot be Granted(08.10.2015)

Australia's High Court has ruled that a gene which greatly increases the chances of breast and ovarian cancer cannot be patented. A US medical researc.....

Tags : Australia Court , Breast Cancer Gene Patent



Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Disclaimer | Copyright 2024 - All Rights Reserved